NGF, EPO, and IGF-1 in the Male Reproductive System
Journal of Clinical Medicine · 15.05.2024 · 13 (10) · 2918
DOI: 10.3390/jcm13102918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.05.2024. Verfasst von Chryssa Metallinou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology, Faculty of Medicine, School of Health Sciences, Democritus University of Thrace, 69100 Alexandroupolis, Greece. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several studies have demonstrated interesting results considering the implication of three growth factors (GFs), namely nerve growth factor (NGF), erythropoietin (EPO), and the insulin-like growth factor-I (IGF-1) in the physiology of male reproductive functions. This review provides insights into the effects of NGF, EPO, and IGF-1 on the male reproductive system, emphasizing mainly their effects on sperm motility and vitality. In the male reproductive system, the expression pattern of the NGF system varies according to the species and testicular development, playing a crucial role in morphogenesis and spermatogenesis. In humans, it seems that NGF positively affects sperm motility parameters and NGF supplementation in cryopreservation media improves post-thaw sperm motility. In animals, EPO is found in various male reproductive tissues, and in humans, the protein is present in seminal plasma and testicular germ cells. EPO receptors have been discovered in the plasma membrane of human spermatozoa, suggesting potential roles in sperm motility and vitality. In humans, IGF-1 is expressed mainly in Sertoli cells and is present in seminal plasma, contributing to cell development and the maturation of spermatozoa. IGF-1 seems to modulate sperm motility, and treatment with IGF-1 has a positive effect on sperm motility and vitality. Furthermore, lower levels of NGF or IGF-1 in seminal plasma are associated with infertility. Understanding the mechanisms of actions of these GFs in the male reproductive system may improve the outcome of sperm processing techniques.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Physiology, Faculty of Medicine, School of Health Sciences, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
- Laboratory of Exercise Physiology and Biochemistry, Department of Physical Education and Sport Science at Serres, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Chryssa Metallinou, Chrysovalanto Staneloudi
Zitieren
APA
Metallinou, C., Staneloudi, C., Nikolettos, K., & Asimakopoulos, B. (2024). NGF, EPO, and IGF-1 in the Male Reproductive System. Journal of Clinical Medicine, 13(10), 2918. https://doi.org/10.3390/jcm13102918
Vancouver
Metallinou C, Staneloudi C, Nikolettos K, Asimakopoulos B. NGF, EPO, and IGF-1 in the Male Reproductive System. Journal of Clinical Medicine. 2024;13(10):2918. doi:10.3390/jcm13102918
BibTeX
@article{Metallinou2024,
author = {Metallinou, Chryssa and Staneloudi, Chrysovalanto and Nikolettos, Konstantinos and Asimakopoulos, Byron},
title = {NGF, EPO, and IGF-1 in the Male Reproductive System},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {10},
pages = {2918},
doi = {10.3390/jcm13102918}
}
EUVIMED